Mindfulness-Based Attention Training Improves Cognitive and Affective Processes in Daily Life in Remitted Patients with Recurrent Depression: A Randomized Controlled Trial

2018 ◽  
Vol 87 (3) ◽  
pp. 184-186 ◽  
Author(s):  
Christina Timm ◽  
Bettina Rachota-Ubl ◽  
Theresa Beddig ◽  
Vera E. Zamoscik ◽  
Ulrich Ebner-Priemer ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Daily Life ◽  
Controlled Trial ◽  
Attention Training ◽  
Recurrent Depression ◽  
Randomized Controlled ◽  
Affective Processes

scholarly journals Effectiveness of Supported Self-Help in Recurrent Depression: A Randomized Controlled Trial in Primary Care

2017 ◽  
Vol 86 (4) ◽  
pp. 220-230 ◽  
Author(s):  
Karolien E.M. Biesheuvel-Leliefeld ◽  
Sandra M.A. Dijkstra-Kersten ◽  
Digna J.F. van Schaik ◽  
Harm W.J. van Marwijk ◽  
Filip Smit ◽  
...  
Keyword(s):  
Primary Care ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Recurrent Depression ◽  
Randomized Controlled ◽  
Self Help

scholarly journals Short and long-arm fiberglass cast immobilization for displaced distal forearm fractures in children: a randomized controlled trial

2020 ◽  
Author(s):  
Michelle Seiler ◽  
Peter Heinz ◽  
Alessia Callegari ◽  
Thomas Dreher ◽  
Georg Staubli ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Range Of Motion ◽  
Daily Life ◽  
Controlled Trial ◽  
Distal Forearm ◽  
Forearm Fractures ◽  
Normal Range ◽  
Randomized Controlled ◽  
Loss Of Reduction ◽  
Distal Forearm Fractures

Abstract Purpose The aim of this study was to investigate whether short-arm fiberglass cast (SAC) immobilization provides fracture stabilization comparable to that of long-arm cast (LAC) treatment of displaced distal forearm fractures after closed reduction in paediatric patients. Methods A prospective, randomized, controlled trial of children aged four to 16 years (mean 9.9 years) was designed with a sample of 120 children, whose size was set a priori, with 60 treated with SAC and 60 with LAC. The primary outcome was fracture stability and rate of loss of reduction. The secondary outcome analysis evaluated duration of analgesic therapy, restriction in activities of daily life, and the duration until patients regained normal range of motion in the elbow. Results No statistically significant differences were found between the two groups in loss of reduction or duration of analgesic therapy. In contrast, the duration until normal range of motion in the elbow was regained was significantly longer in the LAC group (median 4.5 days, P < 0.001). Restriction in activities of daily life did not differ significantly between the two groups except for the item “help needed with showering in the first days after trauma” (SAC 60%, LAC 87%, P = 0.001). Conclusion Fracture immobilization with short-arm fiberglass cast in reduced distal forearm fractures is not inferior to long-arm casts in children four years and older, excluding completely displaced fractures. Furthermore, short-arm casting reduces the need for assistance during showering. Trial registration NCT03297047, September 29, 2017

Preventing Relapse/Recurrence in Recurrent Depression With Cognitive Therapy: A Randomized Controlled Trial.

2005 ◽  
Vol 73 (4) ◽  
pp. 647-657 ◽  
Author(s):  
Claudi L. H. Bockting ◽  
◽  
Aart H. Schene ◽  
Philip Spinhoven ◽  
Maarten W. J. Koeter ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cognitive Therapy ◽  
Controlled Trial ◽  
Recurrent Depression ◽  
Randomized Controlled

scholarly journals The Effect of Attention Process Training (APT-II) On Cognitive and Daily Life Functioning in Patients With a Mild Cognitive Impairment: A Randomized Controlled Trial

2021 ◽  
Author(s):  
Marine Saba ◽  
Jean-Paul Rwabihama ◽  
Éric Bouvard ◽  
Pascale Mettling ◽  
Élise Sztulman ◽  
...  
Keyword(s):  
Older Adults ◽  
Working Memory ◽  
Randomized Controlled Trial ◽  
Cognitive Impairment ◽  
Daily Life ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Life Functioning ◽  
Attention Process ◽  
Attention Process Training

Abstract Introduction. Older adults with mild cognitive impairment (MCI) are at increased risk of developing dementia even if they do not meet the criteria for dementia. Executive control of working memory, which is implicated in divided attention, is often impaired in this population, and such impairment is a strong predictor of dementia. Slowing the development of dementia by enhancing cognitive and brain plasticity represents a current and future challenge for clinicians and researchers. Cognitive rehabilitation allows patients to compensate for cognitive deficits with the ultimate goal of reducing the impact of such deficits on everyday life. We aim to examine the effectiveness and generalization of an attention and working memory training program (Attention Process Training or APT-II) in improving cognitive and everyday functioning in patients with MCI by means of a single-blind, randomized controlled trial.Methods. Twenty-two MCI patients will be randomly assigned to either a "Cognitive Training with APT-II" group or a "Standard Care" group. Initially, patients will be administered a battery of standardized neuropsychological tests to ensure that they meet MCI criteria. The intervention will consist of a cognitive training program (APT-II) and will last 8 weeks (two sessions per week). One of the strengths of APT-II training is that it emphasizes the transfer of cognitive gains from training sessions to everyday life. To evaluate the treatment's effectiveness in improving cognitive and daily life functioning, cognitive and functional outcomes will be assessed just before, immediately after, 3 months after, and 6 months after the intervention program. A divided attention memory task performed in virtual reality will also be administered to evaluate the effects of APT-II training on the management of attentional resources in a relatively ecological situation. Perspective. If our results indicate an improvement in the cognitive and daily life performance of older adults with MCI, this non-invasive, low-cost technique may deserve increased consideration as a therapeutic intervention to delay or reverse cognitive decline an diminish the risk of developing dementia in this population.Trial registration. ClinicalTrials.gov, ID: NCT04606953, Registered on 28 October 2020.

Sign in / Sign up

Export Citation Format

Share Document